Argenx
ARGX
#440
Rank
NZ$92.47 B
Marketcap
NZ$1,485
Share price
0.94%
Change (1 day)
33.48%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): NZ$15.24

According to Argenx 's latest financial reports the company's current EPS (TTM) is NZ$15.40. In 2024 the company made an earnings per share (EPS) of NZ$24.17 an increase over its 2023 EPS that were of NZ-$8.96.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$15.24-36.96%
2024NZ$24.17-369.77%
2023NZ-$8.96-60.46%
2022NZ-$22.6663.33%
2021NZ-$13.88-40.37%
2020NZ-$23.27183.47%
2019NZ-$8.21123.09%
2018NZ-$3.6854.93%
2017NZ-$2.3814.07%
2016NZ-$2.0813.05%
2015NZ-$1.84-36.34%
2014NZ-$2.89209.04%
2013NZ-$0.94-33.99%
2012NZ-$1.42185.59%
2011NZ-$0.50